Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hikma Pharmaceuticals Share News (HIK)
HIK Share
Price
HIK Share
News
HIK Share
Chat
HIK Share
Trades273
HIK
Live RNS1
HIK Share
Charts
HIK Level 2
Console
HIK Live
Share Price
HIK Broker
Ratings
HIK Directors
Deals
HIK Financial
Diary
HIK
Fundamentals
HIK Short
Positions2
HIK
Media
HIK Company
Research
HIK Company
Timeline3
Hikma Pharmaceuticals Information
Share Price Information for Hikma Pharmaceuticals (HIK)
Share Price is delayed by 15 minutes
Get Live Data
1,526.00
-5.00 (-0.33%)
Bid:
1,526.00
Ask:
1,527.00
Spread:
1.00 (0.066%)
Market Cap:
£3.21b
Last checked at -
Last checked at 
Intraday Hikma Pharmaceuticals Share Chart
Hikma Pharmaceuticals News
4 Nov 2020
UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally
UK WINNERS & LOSERS SUMMARY: Pharmaceutical Firms Rally
29 Oct 2020
UK Earnings, Trading Statements Calendar - Next 7 Days
UK Earnings, Trading Statements Calendar - Next 7 Days
20 Oct 2020
Hikma Pharmaceuticals Expands US Collaboration With Arecor
Hikma Pharmaceuticals Expands US Collaboration With Arecor
1 Oct 2020
UK BROKER RATINGS SUMMARY: Goldman Raises Coca-Cola HBC And Cuts DCC
UK BROKER RATINGS SUMMARY: Goldman Raises Coca-Cola HBC And Cuts DCC
22 Sep 2020
IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback
IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback
22 Sep 2020
LONDON MARKET CLOSE: Stocks Rebound Slightly As Covid-19 Fears Remain
LONDON MARKET CLOSE: Stocks Rebound Slightly As Covid-19 Fears Remain
22 Sep 2020
UK WINNERS & LOSERS SUMMARY: Beazley's Virus Claims Estimate Doubles
UK WINNERS & LOSERS SUMMARY: Beazley's Virus Claims Estimate Doubles
22 Sep 2020
Hikma Expects To Gain FDA Approval For Advair Diskus In Early 2021
Hikma Expects To Gain FDA Approval For Advair Diskus In Early 2021
Follow the stocks
